Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17426059 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: gemcitabine hydrochloride;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: vinorelbine tartrate

Indicates status has not been verified in more than two years